|
ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
|
5R00CA158065-04
|
$249,000
|
RINK, LORI
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$135,464
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-36S1
|
$125,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-36
|
$2,600,006
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-02
|
$551,500
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-02
|
$1,549,280
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Viral Oncology Training Grant
|
5T32CA009111-37
|
$373,216
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Viral Non-Coding RNAs and Cell Transformation
|
1R01CA193300-01
|
$271,516
|
STEITZ, JOAN
|
YALE UNIVERSITY
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$24,139
|
Merlino, Glenn
|
CCR (NCI)
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S1
|
$62,500
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-40S2
|
$50,000
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-40
|
$6,231,178
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-02
|
$109,027
|
OGEMBO, JAVIER
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-02
|
$692,055
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S5
|
$1,213,480
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
University of California, Irvine Cancer Center Support Grant
|
3P30CA062203-18S6
|
$48,256
|
VAN ETTEN, RICHARD
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
Underlying Mechanisms in Angiosarcoma
|
1R01CA197943-01
|
$352,275
|
IRUELA-ARISPE, LUISA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
|
5U54CA190153-02
|
$680,259
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
TUMOR-IMPOSED GLUCOSE RESTRICTIONS ON T CELLS DAMPEN IMMUNITY
|
7R01CA181125-02
|
$224,100
|
PEARCE, ERIKA
|
INSTITUT FUR IMMUNBIOLOGIE/EPIGENETIK
|
|
Tumor and Metastasis Biology
|
ZIA BC 010566
|
$371,777
|
Helman, Lee
|
CCR (NCI)
|
|
Training In Tumor Virology
|
5T32CA115299-10
|
$342,954
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Thrombocytes in Cancer Immunity
|
1R01CA188419-01A1
|
$387,236
|
LI, ZIHAI
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Three-dimensional Model of Human Ewing Sarcoma
|
5R01CA180279-02
|
$322,736
|
MIKOS, ANTONIOS
|
RICE UNIVERSITY
|
|
Therapy for NF1-Related Tumors and other Genetic Tumor Predisposition Syndromes
|
ZIA BC 010801
|
$721,563
|
Widemann, Brigitte
|
CCR (NCI)
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
1P30CA196521-01
|
$1,695,000
|
BURAKOFF, STEVEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
The Role of miRNA-mediated RNAI in the Biology of Cancer
|
ZIA BC 010612
|
$101,154
|
Caplen, Natasha
|
CCR (NCI)
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-21S1
|
$79,482
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-21
|
$4,814,560
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Induction of Gene-specific RNAi Against Cancer-associated Genes
|
ZIA BC 010613
|
$404,618
|
Caplen, Natasha
|
CCR (NCI)
|
|
TGIB Surgical Oncology Fellowship Program
|
ZIE BC 011542
|
$971,915
|
Schrump, David
|
CCR (NCI)
|
|
TGIB Surgical Consultative Services
|
ZID BC 011541
|
$1,851,267
|
Schrump, David
|
CCR (NCI)
|
|
Targeting vFLIP for the treatment of KSHV-associated malignancies
|
5R01CA154228-05
|
$350,675
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-02
|
$423,409
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Targeting Tumor Cell Iron Addiction to Achieve Tumor-Selective Cell Death
|
5R00CA166517-04
|
$236,010
|
DIXON, SCOTT
|
STANFORD UNIVERSITY
|
|
Targeting KSHV malignancies and persistent infection
|
1R01CA197153-01
|
$377,247
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Targeting FGFR4, RAS, and PAX3-FOXO1 gene in Rhabdomyosarcoma
|
ZIA BC 010999
|
$539,792
|
Khan, Javed
|
CCR (NCI)
|
|
Targeting FAK and integrin signaling in preclinical models of Ewing sarcoma
|
1K08CA188073-01A1
|
$177,120
|
CROMPTON, BRIAN
|
DANA-FARBER CANCER INST
|
|
Targeting CXCR4 and microRNA as Therapy for Chondrosarcoma
|
5R01CA166089-03
|
$280,000
|
TEREK, RICHARD
|
RHODE ISLAND HOSPITAL
|
|
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
|
5R01CA163217-05
|
$305,754
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Surgical Guidance of Soft Tissue Sarcoma Excision Using Fluorescence Imaging and
|
1F31CA200358-01
|
$43,120
|
NGUYEN, JOHN QUAN
|
VANDERBILT UNIVERSITY
|
|
Studying the role of KSHV-encoded miRNAs
|
5R01CA119917-08
|
$301,913
|
RENNE, ROLF
|
UNIVERSITY OF FLORIDA
|
|
Study the roles of p53 and p53 mutants in mesenchymal stem cells
|
ZIA BC 011504
|
$388,779
|
Huang, Jing
|
CCR (NCI)
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$675,862
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$163,092
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
Studies of gene fusions in rhabdomyosarcoma
|
ZIA BC 011387
|
$339,748
|
Barr, Frederic
|
CCR (NCI)
|
|
Studies of Childhood Sarcomas
|
7P01CA165995-03
|
$1,619,923
|
HOUGHTON, PETER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$292,561
|
Barr, Frederic
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|